FIELD: biotechnologies.
SUBSTANCE: use of live metapneumovirus of birds (AMPV) and pharmaceutical composition containing cytotoxic quantity of such virus, in therapies of malignant tumours, and also the method of therapy of malignant tumours using the named pharmaceutical composition are offered.
EFFECT: metapneumovirus of birds is characterized by the expressed cytolytic action on tumour cells, and the pharmaceutical compositions containing cytotoxic quantity of this virus can be used in medicine in the methods of therapy of malignant tumours as an alternative instead of pharmaceutical compositions containing known oncolytic viruses.
17 cl, 1 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EXTENDED ADOPTIVE CELL THERAPY | 2014 |
|
RU2703438C2 |
| APPLICATION OF MYXOMA VIRUS FOR THERAPEUTIC TREATMENT OF CANCER AND CHRONIC VIRUS INFECTION | 2004 |
|
RU2362584C2 |
| ONCOLYTIC ADENOVIRUSES ENCODING BISPECIFIC ANTIBODIES, AS WELL AS METHODS AND APPLICATIONS ASSOCIATED THEREWITH | 2016 |
|
RU2725799C2 |
| USE OF COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT | 2006 |
|
RU2461630C2 |
| USE OF GENETICALLY MODIFIED PATHOGENIC MEASLES VIRUS WITH IMPROVED APOPTOTIC PROPERTIES (MV-DELTAC VIRUS) IN CANCER THERAPY | 2014 |
|
RU2700083C2 |
| ONCOLYTIC VIRUS FOR IMMUNOLOGIC CONTROL POINT MODULATORS EXPRESSION | 2015 |
|
RU2696312C2 |
| ONCOLYTIC ADENOVIRUS FOR TREATING CANCER, USING IT, AND PHARMACEUTICAL COMPOSITION CONTAINING IT | 2010 |
|
RU2536931C2 |
| M2-DEFECTIVE POXVIRUS | 2019 |
|
RU2819245C2 |
| THERAPEUTIC COMPOSITIONS AND METHODS OF USING FOR TREATING CANCER | 2016 |
|
RU2720984C2 |
| TREATMENT OF TUMORS WITH A COMBINATION OF ONCOLYTIC ADENOVIRUS AND CDK4/6 INHIBITOR | 2019 |
|
RU2811278C2 |
